Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma

被引:26
作者
Temple, William C. [1 ,2 ]
Vo, Kieuhoa T. [1 ,2 ]
Matthay, Katherine K. [1 ,2 ]
Balliu, Brunilda [3 ]
Coleman, Christina [4 ]
Michlitsch, Jennifer [4 ]
Phelps, Andrew [5 ]
Behr, Spencer [5 ]
Zapala, Matthew A. [5 ]
机构
[1] UCSF Sch Med, Dept Pediat, 1975 Fourth St, San Francisco, CA 94158 USA
[2] UCSF Benioff Childrens Hosp, 1975 Fourth St, San Francisco, CA 94158 USA
[3] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA
[4] UCSF Benioff Childrens Hosp, Dept Hematol & Oncol, Oakland, CA USA
[5] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA
来源
CANCER MEDICINE | 2021年 / 10卷 / 07期
关键词
pathology; pediatric cancer; surgical oncology; survival; EUROPEAN-INTERNATIONAL-SOCIETY; LOCALIZED NEUROBLASTOMA; NEOADJUVANT CHEMOTHERAPY; MYCN AMPLIFICATION; CLASSIFICATION; STRATEGIES; GENOMICS; LNESG1;
D O I
10.1002/cam4.3663
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Clinical, molecular, and histopathologic features guide treatment for neuroblastoma, but obtaining tumor tissue may cause complications and is subject to sampling error due to tumor heterogeneity. We hypothesized that image-defined risk factors (IDRFs) would reflect molecular features, histopathology, and clinical outcomes in neuroblastoma. Methods We performed a retrospective cohort study of 76 patients with neuroblastoma or ganglioneuroblastoma. Diagnostic CT scans were reviewed for 20 IDRFs, which were consolidated into five IDRF groups (involvement of multiple body compartments, vascular encasement, tumor infiltration of adjacent organs/structures, airway compression, or intraspinal extension). IDRF groups were analyzed for association with clinical, molecular, and histopathologic features of neuroblastoma. Results Patients with more IDRF groups had a higher risk of surgical complications (OR = 3.1, p = 0.001). Tumor vascular encasement was associated with increased risk of surgical complications (OR = 5.40, p = 0.009) and increased risk of undifferentiated/poorly differentiated histologic grade (OR = 11.11, p = 0.013). Tumor infiltration of adjacent organs and structures was associated with decreased survival (HR = 8.90, p = 0.007), MYCN amplification (OR = 9.91, p = 0.001), high MKI (OR = 6.20, p = 0.003), and increased risk of International Neuroblastoma Staging System stage 4 disease (OR = 8.96, p < 0.001). Conclusions The presence of IDRFs at diagnosis was associated with high-risk clinical, molecular, and histopathologic features of neuroblastoma. The IDRF group tumor infiltration into adjacent organs and structures was associated with decreased survival. Collectively, these findings may assist surgical planning and medical management for neuroblastoma patients.
引用
收藏
页码:2232 / 2241
页数:10
相关论文
共 33 条
  • [1] Chromosome 1p and 11q deletions and outcome in neuroblastoma
    Attiyeh, EF
    London, WB
    Mossé, YP
    Wang, Q
    Winter, C
    Khazi, D
    McGrady, PW
    Seeger, RC
    Look, AT
    Shimada, H
    Brodeur, GM
    Cohn, SL
    Matthay, KK
    Maris, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21) : 2243 - 2253
  • [2] Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes
    Avanzini, Stefano
    Pio, Luca
    Erminio, Giovanni
    Granata, Claudio
    Holmes, Keith
    Gambart, Marion
    Buffa, Piero
    Castel, Victoria
    Couanet, Dominique Valteau
    Garaventa, Alberto
    Pistorio, Angela
    Cecchetto, Giovanni
    Martucciello, Giuseppe
    Mattioli, Girolamo
    Sarnacki, Sabine
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [3] Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
    Bosse, Kristopher R.
    Maris, John M.
    [J]. CANCER, 2016, 122 (01) : 20 - 33
  • [4] Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival
    Brisse, Herve J.
    Blanc, Thomas
    Schleiermacher, Gudrun
    Mosseri, Veronique
    Philippe-Chomette, Pascale
    Janoueix-Lerosey, Isabelle
    Pierron, Gaelle
    Lapouble, Eve
    Peuchmaur, Michel
    Freneaux, Paul
    Galmiche, Louise
    Algret, Nathalie
    Peycelon, Matthieu
    Michon, Jean
    Delattre, Olivier
    Sarnacki, Sabine
    [J]. PLOS ONE, 2017, 12 (09):
  • [5] Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
    Brisse, Herve J.
    McCarville, M. Beth
    Granata, Claudio
    Krug, K. Barbara
    Wootton-Gorges, Sandra L.
    Kanegawa, Kimio
    Giammarile, Francesco
    Schmidt, Matthias
    Shulkin, Barry L.
    Matthay, Katherine K.
    Lewington, Valerie J.
    Sarnacki, Sabine
    Hero, Barbara
    Kaneko, Michio
    London, Wendy B.
    Pearson, Andrew D. J.
    Cohn, Susan L.
    Monclair, Tom
    [J]. RADIOLOGY, 2011, 261 (01) : 243 - 257
  • [6] REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT
    BRODEUR, GM
    PRITCHARD, J
    BERTHOLD, F
    CARLSEN, NLT
    CASTEL, V
    CASTLEBERRY, RP
    DEBERNARDI, B
    EVANS, AE
    FAVROT, M
    HEDBORG, F
    KANEKO, M
    KEMSHEAD, J
    LAMPERT, F
    LEE, REJ
    LOOK, AT
    PEARSON, ADJ
    PHILIP, T
    ROALD, B
    SAWADA, T
    SEEGER, RC
    TSUCHIDA, Y
    VOUTE, PA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) : 1466 - 1477
  • [7] Neuroblastoma: Biological insights into a clinical enigma
    Brodeur, GM
    [J]. NATURE REVIEWS CANCER, 2003, 3 (03) : 203 - 216
  • [8] Surgical risk factors in primary surgery for localized neuroblastoma:: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group
    Cecchetto, G
    Mosseri, V
    De Bernardi, B
    Helardot, P
    Monclair, T
    Costa, E
    Horcher, E
    Neuenschwander, S
    Tomà, P
    Rizzo, A
    Michon, J
    Holmes, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) : 8483 - 8489
  • [9] A review of neuroblastoma image-defined risk factors on magnetic resonance imaging
    Chen, Alan M.
    Trout, Andrew T.
    Towbin, Alexander J.
    [J]. PEDIATRIC RADIOLOGY, 2018, 48 (09) : 1337 - 1347
  • [10] The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
    Cohn, Susan L.
    Pearson, Andrew D. J.
    London, Wendy B.
    Monclair, Tom
    Ambros, Peter F.
    Brodeur, Garrett M.
    Faldum, Andreas
    Hero, Barbara
    Iehara, Tomoko
    Machin, David
    Mosseri, Veronique
    Simon, Thorsten
    Garaventa, Alberto
    Castel, Victoria
    Matthay, Katherine K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 289 - 297